Business Description
Ironwood Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US46333X1081
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | -0.74 | |||||
Debt-to-Equity | -2.07 | |||||
Debt-to-EBITDA | -0.77 | |||||
Interest Coverage | 7.82 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -9.78 | |||||
Beneish M-Score | -3.92 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year FCF Growth Rate | 4.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.69 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.47 | |||||
9-Day RSI | 46.9 | |||||
14-Day RSI | 40.95 | |||||
6-1 Month Momentum % | -8.24 | |||||
12-1 Month Momentum % | -18.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.84 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.33 | |||||
Days Sales Outstanding | 99.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -17.85 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 38.02 | |||||
Net Margin % | -226.37 | |||||
FCF Margin % | 41.44 | |||||
ROE % | -1456.68 | |||||
ROA % | -130.02 | |||||
ROIC % | 38.76 | |||||
ROC (Joel Greenblatt) % | -974.75 | |||||
ROCE % | -157.43 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.1 | |||||
Price-to-Free-Cash-Flow | 7.66 | |||||
Price-to-Operating-Cash-Flow | 7.64 | |||||
EV-to-EBIT | -1.99 | |||||
EV-to-EBITDA | -1.99 | |||||
EV-to-Revenue | 4.16 | |||||
EV-to-FCF | 10.31 | |||||
Price-to-Projected-FCF | 1.57 | |||||
Price-to-Median-PS-Value | 0.58 | |||||
Earnings Yield (Greenblatt) % | -50.23 | |||||
FCF Yield % | 15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ironwood Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 410.676 | ||
EPS (TTM) (€) | -6.005 | ||
Beta | 0.37 | ||
Volatility % | 51.01 | ||
14-Day RSI | 40.95 | ||
14-Day ATR (€) | 0.194784 | ||
20-Day SMA (€) | 7.4575 | ||
12-1 Month Momentum % | -18.32 | ||
52-Week Range (€) | 7.1 - 14.5 | ||
Shares Outstanding (Mil) | 156.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ironwood Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ironwood Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ironwood Pharmaceuticals Inc Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc(FRA:I76)'s stock price today?
When is next earnings date of Ironwood Pharmaceuticals Inc(FRA:I76)?
Does Ironwood Pharmaceuticals Inc(FRA:I76) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |